BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28189721)

  • 1. 1,2-Dichloroethane impairs glucose and lipid homeostasis in the livers of NIH Swiss mice.
    Wang T; Xu D; Fan Q; Rong W; Zheng J; Gao C; Li G; Zeng N; Guo T; Zeng L; Wang F; Xiao C; Cai L; Tang S; Deng X; Yin X; Huang M; Lu F; Hu Q; Chen W; Huang Z; Wang Q
    Toxicology; 2017 Apr; 380():38-49. PubMed ID: 28189721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of miR-451a contributes to 1,2-dichloroethane-induced hepatic glycerol gluconeogenesis disorder by inhibiting glycerol kinase expression in NIH Swiss mice.
    Zeng N; Jiang H; Fan Q; Wang T; Rong W; Li G; Li R; Xu D; Guo T; Wang F; Zeng L; Huang M; Zheng J; Lu F; Chen W; Hu Q; Huang Z; Wang Q
    J Appl Toxicol; 2018 Feb; 38(2):292-303. PubMed ID: 28960355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-241 inhibits 1,2-Dichloroethane-induced hepatic apoptosis.
    Zeng N; Zhang Z; Jiang H; Li R; Chang C; Wang F; Xu D; Fan Q; Wang T; Xiao Y; Chen W; Shan Z; Huang Z; Wang Q
    Toxicol In Vitro; 2019 Dec; 61():104650. PubMed ID: 31520740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
    Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM
    J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of CYP2e1 in 1,2-dichloroethane-induced liver damage in mice.
    Sun Q; Wang G; Gao L; Shi L; Qi Y; Lv X; Jin Y
    Environ Toxicol; 2016 Nov; 31(11):1430-1438. PubMed ID: 25926354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
    Yavarow ZA; Kang HR; Waskowicz LR; Bay BH; Young SP; Yen PM; Koeberl DD
    Hum Mol Genet; 2020 Jan; 29(2):286-294. PubMed ID: 31816064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplementation of salidroside alleviates liver lipid metabolism disorder and inflammatory response to promote hepatocyte regeneration via PI3K/AKT/Gsk3-β pathway.
    Cui Z; Jin N; Amevor FK; Shu G; Du X; Kang X; Ning Z; Deng X; Tian Y; Zhu Q; Wang Y; Li D; Zhang Y; Wang X; Han X; Feng J; Zhao X
    Poult Sci; 2022 Sep; 101(9):102034. PubMed ID: 35926351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes.
    Rufinatscha K; Radlinger B; Dobner J; Folie S; Bon C; Profanter E; Ress C; Salzmann K; Staudacher G; Tilg H; Kaser S
    Biochem Biophys Res Commun; 2017 Apr; 485(2):366-371. PubMed ID: 28213130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
    Kaneko K; Soty M; Zitoun C; Duchampt A; Silva M; Philippe E; Gautier-Stein A; Rajas F; Mithieux G
    Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2-Dichloroethane-induced hepatotoxicity and apoptosis by inhibition of ERK 1/2 pathways.
    Pang Y; Qi G; Jiang S; Zhou Y; Li W
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1119-1126. PubMed ID: 29852074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucosylated chondroitin sulfate from sea cucumber in combination with rosiglitazone improved glucose metabolism in the liver of the insulin-resistant mice.
    Hu S; Chang Y; Wang J; Xue C; Li Z; Wang Y
    Biosci Biotechnol Biochem; 2013; 77(11):2263-8. PubMed ID: 24200792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of perinatal exposure to BPA and its alternatives (BPS, BPF and BPAF) on hepatic lipid and glucose homeostasis in female mice adolescent offspring.
    Meng Z; Wang D; Yan S; Li R; Yan J; Teng M; Zhou Z; Zhu W
    Chemosphere; 2018 Dec; 212():297-306. PubMed ID: 30145421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
    Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
    Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
    Garcia Caraballo SC; Comhair TM; Houten SM; Dejong CH; Lamers WH; Koehler SE
    J Nutr Biochem; 2014 Dec; 25(12):1263-74. PubMed ID: 25287814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
    Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2-Dichloroethane Induces Reproductive Toxicity Mediated by the CREM/CREB Signaling Pathway in Male NIH Swiss Mice.
    Zhang Y; Li G; Zhong Y; Huang M; Wu J; Zheng J; Rong W; Zeng L; Yin X; Lu F; Xie Z; Xu D; Fan Q; Jia X; Wang T; Hu Q; Chen W; Wang Q; Huang Z
    Toxicol Sci; 2017 Dec; 160(2):299-314. PubMed ID: 28973639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
    Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.